Comparison of infliximab with adalimumab in 827 biologic-naïve patients with Crohn's disease: a population-based Danish cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of infliximab with adalimumab in 827 biologic-naïve patients with Crohn's disease: a population-based Danish cohort study

Published:2017-12-14 Issue:5 Volume:47 Page:596-604
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Singh S.¹^ORCID,Andersen N. N.²,Andersson M.²,Loftus E. V.³,Jess T.²⁴^ORCID

Affiliation:

1. Division of Gastroenterology; University of California San Diego; La Jolla CA USA

2. Department of Epidemiology Research; Statens Serum Institute; Copenhagen Denmark

3. Divison of Gastroenterology and Hepatology; Mayo Clinic; Rochester MN USA

4. Institute of Preventive Medicine; Bispebjerg and Frederiksberg Hospital; Copenhagen Denmark

Funder

American College of Gastroenterology

Crohn's and Colitis Foundation of America

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.14466/fullpdf

Reference29 articles.

1. Tumor necrosis factor inhibitors for inflammatory bowel disease;Nielsen;N Engl J Med,2013

2. Practice parameters committee of the American College of G. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee;Kornbluth;Am J Gastroenterol,2010

3. Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab;Sandborn;Gastroenterology,2009

4. Adalimumab therapy is associated with reduced risk of hospitalization in patients with ulcerative colitis;Feagan;Gastroenterology,2014

5. Update on anti-tumor necrosis factor agents in Crohn disease;Singh;Gastroenterol Clin North Am,2014

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How comparative studies can inform treatment decisions for Crohn’s disease;Expert Opinion on Biological Therapy;2024-08-12

2. Author's Reply: “Immunomodulator combination versus mono therapy: Does combination therapy have an impact on infliximab therapy?”;Digestive and Liver Disease;2024-03

3. Clinical use of biologics for Crohn’s disease in adults: lessons learned from real-world studies;Expert Opinion on Biological Therapy;2024-02-23

4. Immunomodulator combination versus mono therapy: Does combination therapy have an impact on infliximab therapy?;Digestive and Liver Disease;2023-12

5. Comparative Effectiveness Research: A Roadmap to Sail the Seas of IBD Therapies;Journal of Clinical Medicine;2022-11-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3